Terbutaline has 20 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Insulin Glargine, Succinylcholine Chloride, Glimepiride. Patients taking Terbutaline should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 20
- Major
- 2
- Moderate
- 18
Major (2)
- Terbutaline + Insulin Glargine— May decrease blood glucose lowering effect of LANTUS. Dosage increases and increased glucose monitoring may be required.
- Terbutaline + Succinylcholine Chloride— May enhance the neuromuscular blocking action of succinylcholine.
Moderate (18)
- Terbutaline + Glimepiride— Sympathomimetic that may reduce glucose-lowering effect of glimepiride, leading to worsening glycemic control.
- Terbutaline + Glipizide— May reduce glucose-lowering effect of glipizide, leading to worsening glycemic control; monitor closely.
- Terbutaline + Histamine Phosphate— Oral beta 2 agonist that decreases allergen-induced wheal and may reduce whealing capacity to histamine.
- Terbutaline + Insulin Aspart Injection— Sympathomimetic agent that may decrease the blood glucose lowering effect. Dose adjustment and increased glucose monitor…
- Terbutaline + Insulin Aspart-Szjj— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
- Terbutaline + Insulin Degludec— Sympathomimetic agent that may decrease blood glucose lowering effect. Dosage increases and increased glucose monitoring…
- Terbutaline + Insulin Degludec And Liraglutide— Sympathomimetic agent that may decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring…
- Terbutaline + Insulin Detemir— May decrease blood glucose lowering effect of insulin detemir. Dosage increases and increased glucose monitoring may be …
- Terbutaline + Insulin Glargine And Lixisenatide— Sympathomimetic agent that may decrease the blood glucose lowering effect. Dose increases and increased glucose monitori…
- Terbutaline + Insulin Glargine-Aglr— Sympathomimetic agent that may decrease blood glucose lowering effect. Dosage increases and increased glucose monitoring…
- Terbutaline + Insulin Glargine-Yfgn— Sympathomimetic agent that may decrease blood glucose lowering effect. Dosage increases and increased glucose monitoring…
- Terbutaline + Insulin Glulisine— Sympathomimetic agent may decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may b…
- Terbutaline + Insulin Human— Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and glucose monitoring may be req…
- Terbutaline + Insulin Icodec-Abae— May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
- Terbutaline + Insulin Lispro— Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring …
- Terbutaline + Insulin Lispro-Aabc— Sympathomimetic agent that may decrease blood glucose lowering effect. Dose increases and increased glucose monitoring m…
- Terbutaline + Sotalol Hydrochloride— Beta-agonist; may require increased dosages when used concomitantly with sotalol.
- Terbutaline + Succinylcholine— May enhance the neuromuscular blocking action of succinylcholine.